Skip to content
Application 021858
- Type
- NDA
- Sponsor
- ROCHE
Application Products#
Product, Drug, Ingredient table| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|
| 001 | BONIVA | IBANDRONATE SODIUM | INJECTABLE;INTRAVENOUS | EQ 3MG BASE/3ML | Yes | Yes |
NDC Listings For This Application#
NDC, Name, Nonproprietary name table| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|
| 0004-0191 | Boniva | ibandronate sodium | Genentech, Inc. | NDA | Current |
| 0004-0191 | Boniva | ibandronate sodium | Genentech, Inc. | NDA | Current |
| 0004-0191 | Boniva | ibandronate sodium | Genentech, Inc. | NDA | Current |
| 0004-0191 | Boniva | ibandronate sodium | Genentech, Inc. | NDA | Current |